Skip to content
OpenCapital
Get started

Aura Biosciences, Inc. AURA Gain on termination of lease

Gain on termination of lease at other companies

MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$100K+133%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnTerminationOfLease.

The official record: Aura Biosciences, Inc.’s 10-K, filed March 27, 2024, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s gain on termination of lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s gain on termination of lease?
Aura Biosciences, Inc. (AURA) reported gain on termination of lease of -$74K in Q4 2022.